Article info
PDFPostScript
Letter
Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
- Correspondence to Professor Dae Won Jun, Department of Internal Medicine, Hanyang University College of Medicine, Seongdong-gu, Seoul 133-792, Korea (the Republic of); noshin{at}hanyang.ac.kr; Dr Eun-Hee Nah, Department of Laboratory Medicine, Health Promotion Research Institute, Gangseo-gu, Seoul 07572, Republic of Korea; cellonah{at}hanmail.net
Citation
Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
Publication history
- Received May 5, 2021
- Accepted June 5, 2021
- First published June 14, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (8 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.